Investigational Agent Eases Post-Bariatric Hypoglycemia
Summary
Avexitide, a GLP-1 receptor antagonist, could become the first approved treatment for the debilitating condition.
Description from Medscape.
Who is covering this
-
Investigational Agent Eases Post-Bariatric Hypoglycemia
Avexitide, a GLP-1 receptor antagonist, could become the first approved treatment for the debilitating condition.
Comments
Comments need JavaScript.